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INTRODUCTION 
The commercialization of baculovirus-
es has had a long, variable history. En-
tomologists early on recognized that 
thèse viruses could be utilized as in-
sect-specific control tools and numer-
ous attempts were made to develop 
the wild-type viruses as commercial in-
secticides. Some of the earlier prod-
ucts were Elcar™, Gypcheck™, 
Neocheck-S™, and more recently, prod-
ucts from ThermoTrilogy, GemStar™ 
and Spod-X™. Thèse latter products 
are presently being commercially pro-
duced and marketed in various loca-
tions around the world. While the wild-
type baculoviruses hâve realized a small 
level of success, the real commercial 
potential lies in an insect-specific insec-
ticide that will effectively control an 
insect population equal to, or close to, 
the same efficiency as commercial in-
secticides. The advent of understand-
ing the genetic code and the manipula-
tion of it hâve introduced a whole new 
era for exploration and development 
(i.e.,the production of transgenic insect 
viruses for insect control). The use of 
thèse tools to insert toxin gènes which, 
when expressed, can speed the killing 
effect of a baculovirus, is the subject of 
research ongoing in two major corpo-
rations, DuPont and American Cyana-
mid. Through the insertion and expres-
sion of heterologous gènes in a 
baculovirus vector, the long-term prob-
lem of slow kill of a baculovirus is over-
come. This is achieved by altering 
the mode-of-action of the baculovirus 
[i.e., the virus kills the insect via the 
expression of a protein (chemical) vs. 
consuming virtually every cell in the 
insect body to affect reproduction of 
the virus itself]. Since the recombinant 
baculovirus is a changed from the wild-
type, one must assess the recombinant 
for new properties for a potentially dif-
férent environmental impact as com-
parée! to its wild-type parent. This is 
one of the issues we are ail hère to 
discuss (i.e., what are the research chal-
lenges that face us in the safe utilization 
of thèse new transgenic insecticide 
tools?). 
Let's look at the various safety as-
pects surrounding each of the two com-
ponents of this new System that hâve 
been broughttogether: (1) the baculov-
irus, and (2) the toxin gène. 
BACULOVIRUS SAFETY 
There has been a long, close evolution-
ary relationship between baculoviruses 
and arthropods. This has led to very 
spécifie evolutionary adaptations due 
to this close relationship. Probably the 
best illustration of this co-evolution is 
represented by the occlusion body, a 
proteinacious crystal that dissolves only 
at a high pH and is extremely sensitive 
to the high pH found in the target insect 
midgut. This occlusion body allows the 
occluded virions to survive in the envi-
ronment but, upon consumption by a 
target host, is readily dissolved and able 
to quickly infect the midgut cells of the 
insect. The infection expands from that 
point throughout the whole insectbody. 
Conversely, the vertebrate digestive 
tract, is usually neutral or acidic. The 
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occlusion body will either pass through 
the vertebrate digestive tract or become 
inactivated during the digestion process. 
The safety of baculoviruses has been 
widely evaluated over the last 30 years. 
Several summaries are available (Dol-
ler, 1985; Burges et ai, 1980, Ignoffo, 
1973, 1975). Safety studies with bacu-
loviruses hâve been conducted on mice, 
guinea pigs, rats, monkeys, and even 
humans. AH data indicate that bacu-
loviruses are safe. In the human study, 
Helicoverpa zea NPV polyhedra were 
ingested by 10 individuals at a dose of 
ca. 6 billion polyhedra over a 5-day 
period (Heimpel and Buchanan, 1967) 
which caused no ill effects. In a longer-
term study, 6 persons were exposed to 
NPV during 26 months of commercial 
production, and showed no adverse 
effects of this long-term exposure (Hua-
ng et ai, 1977). Analysis and bioassay 
of blood samples did not find any bac-
uloviral antigens, antibodies, or any in-
fectious baculovirus in blood samples. 
One interesting factor is the environ-
mental load of NPVs that humans are 
exposed to on a regular basis. Heimpel 
et al. (1973) showed that polyhedron 
counts on cabbage taken from super-
market shelves contained between 2 
and 100 million polyhedra per square 
inch. Heimpel estimated, using thèse 
numbers, that a typical cole slaw serv-
ing might contain as many as 1 x 108 
polyhedra. So, as you can see, we are 
constantly exposed to thèse viruses. 
Baculoviruses hâve also demonstrat-
ed safety even within the invertebrates. 
Baculoviruses, for the most part, hâve 
g very limited host-ranges, mostly infect-
2 ing the order Lepidoptera, and in gen-
3 eral, infecting only a few species in any 
a genus. 
w 
jjj TOXIN SAFETY 
g 
o Commercial companies hâve chosen 
H insect-specific toxins, whose respective 
S gènes are utilized, to incorporate in the 
O baculovirus génome. This essentially 
£ gives a double layer of safety to the 
J viral construct (i.e., the virus is the first 
limiting factor with its insect specificity, 
and the toxin gène is limiting also be-
cause of its insect specificity). Ameri-
can Cyanamid and DuPont hâve both 
chosen initially two scorpion toxin 
gènes, AalT, from the scorpion, Androc-
tonus australis, and the LqlT gène from 
the scorpion, Leiurus quinquestritus 
hebrus, respectively. Significant re-
search has been conducted on both 
toxins. Zlotkin et al. (1991, 1993) and 
Moskowitz et al. (1994) demonstrated 
that both toxins are insect-specific. 
ECOLOGICAL ISSUES 
It is well-known in the literature that 
occlusion bodies of baculoviruses can 
persist for many years in soil. The 
addition of an insect-specific toxin gène 
does not affect this physical character-
istic of the virus, therefore, one would 
anticipate that its persistence in the 
environment would parallel that of its 
wild-type parent. Perhaps a more im-
portant issue is whether the recombi-
nant virus could become established in 
the environment, increase in number, 
and initiate epizootics unrelated to its 
original intent of introduction as a bio-
pesticide to control or suppress a pest 
insect. When one considers basic bio-
logical principles and the available data, 
the suggestion is that it is very unlikely 
that the recombinant could supplant its 
wild-type parent and unbalance the 
scales of nature. 
The main goal of genetic enginee-
ring of a baculovirus is to increase the 
speed-of-kill of the target pest. As pre-
viously mentioned, the kill time for a 
wild-type virus varies from 5-15 days, 
with the genetically engineered virus, 
this can be reduced to 2 - 3 days -
obviously a major benefit in protecting 
a crop. Theoretically, if this resuit is 
achieved, the virus would go through a 
reduced number of reproductive cycles, 
thus reducing the amount of virus pro-
duced, compared to the wild-type pa-
rental strain. Expérimental results with 
the baculovirus containing the AalT 
toxin indicate that the recombinant 
produces 75-93% fewer polyhedra, 
compared to the wild-type parent (Amer-
ican Cyanamid, 1994). Compétition 
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studies (wild-type vs. recombinant bac-
ulovirus) indicate that the wild-type was 
able to out-compete and overcome the 
phenotypic expression of the constric-
tive paralysis demonstrated by a bacu-
lovirus containing the AalT gène. In 
one such study conducted at American 
Cyanamid, a 1:10 mixture of the wild-
type to AalT-expressing recombinant, 
was fed to larvae of the permissive 
insect, Heliothis virescens. After 6 days, 
ail of the larvae in each dose were 
harvested and processed to extract the 
polyhedra. Each mixture was then fed 
to a second génération of larvae. This 
process was continued for 6 généra-
tions. Two methods were used to track 
the amount of AalT-expressing virus, 
the contractile phenotype, and molecu-
lar analysis of the viral génomes in 
the final polyhedra extractions. The 
results demonstrated a rapid decrease 
in the AalT-expressing virus and a 
rapid increase in the wild-type parent. 
In 6 générations, the AalT phenotype 
and génotype were lost. Very clearly, 
the recombinant is less fit to survive in 
the environment, and would hâve con-
siderably less environmental impact 
than its wild-type parent. The data 
indicate that the recombinant would be 
unable to displace the parental strain. 
Wood (1991) indicated that one area 
for concern is genetic transfer or genet-
ic reassortment (i.e., could the release 
of a recombinant baculovirus enable 
that recombinant to transfer its heterol-
ogous gène into other related or unre-
lated viruses, thus introducing poten-
tial conséquences of unknown resuit?). 
Two issues must be considered when 
evaluating the potential of an inserted 
gène from a recombinant baculovirus 
jumping to another organism: (1) what 
is the likelihood of a genetic exchange 
occurring between the recombinant 
baculovirus and another organism? and 
(2) what would the conséquences of 
such an event be? 
It is an established fact that genetic 
exchange can and does occur in nature. 
However, the integrity of a species is 
protected by significant barriers to gène 
movement, which can limit or reduce 
the likelihood of genetic exchange. 
Several barriers to exchange exist. The 
first barrier to genetic exchange, is that 
both the donor and récipient organism 
must be replicating at the same time in 
the same cell of an infected insect. 
Thèse time and space requirements 
pose limits on the likelihood of ex-
change. The fact that thèse baculovi-
ruses reproduce in the nucleus, requires 
that they not only be in the same cell, 
but that they also be in the same cell 
compartment (the nucleus). 
Another important barrier to genetic 
exchange is the relationship of genetic 
material of the donor and of the récip-
ient. Even if the two viruses infect the 
same host cell at the same time in the 
same cellular compartment, différenc-
es in replication and composition of viral 
génome can serve to limit exchange of 
genetic information. Thèse factors re-
alistically limit situations, where an 
exchange of genetic information could 
occur, to two highly related baculovi-
ruses. 
The conséquences of any genetic 
exchange, assuming they occur, would 
be extremely limited. New genetic traits 
will become "fixed" in a population only 
if they confer a sélective advantage to 
the species. As indicated earlier, the 
heterologous toxin gène significantly 
reduces the fitness of the recombinant 
virus to persist in the environment. It 
would follow that any new virus acquir-
ing a toxin gène would also be environ-
mentally less fit. 
BENEFITS 
Biotechnology obviously will hâve sig-
nificant économie and societal benefits 
to agriculture in the future. We are 
beginning to reap some of thèse bene-
fits through herbicide-tolérant and Bt-
producing crops. The commercial avail-
ability of transgenic insect viruses for 
use as insecticides is certain within the 
next 2 - 3 years. This first génération 
of transgenic baculoviruses, as I hâve 
previously discussed, passed the basic 
parameters for environmental and tox-
icological safety. However, there is one 
issue which is the most important and 
thus saved for the final discussion, that 
being the problem of societal issues. 
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Biotechnology has corne under gênerai 
public scrutiny and certain environmen-
tal activist groups hâve attacked bio-
technology from scientific, ethical, and 
Personal viewpoints. Meeting the chal-
lenge of thèse societal issues is going 
to be the greater challenge in the intro-
duction of biotechnology, whether it's 
genetically manipulated plants or mi-
croorganisms. The major question is 
"How do we overcome ignorance, fear, 
and ethical concerns as they relate to 
their négative impact on the use of 
biotechnology in gênerai, and more 
directly, transgenic baculoviruses?". 
In the past, we (as crédible scientists) 
hâve been able to tell the public that ail 
is okay, and they hâve accepted it. 
However, the credibility of the scientific 
community has been eroded through 
certain négative expériences, especial-
ly in the areas of nuclear physics and 
chemistry. Principles were described 
by Brown (1987) which show the essen-
tials of dealing with the public sector. 
Thèse hâve great applicability to com-
municating the aspects of biotechnolo-
gy. Thèse are: (1) don't dismiss lay 
hypothèses as ridiculous; (2) never ig-
nore non-scientific points about biotech-
nology; and (3) never underestimate the 
intelligence or power of the public. 
Basically, the above principles spell out 
clearly that any hypothèses, fears, ig-
norances, etc. that arise must be ex-
plained as openly and clearly as possi-
ble. The public must understand that 
the communications they are receiving 
are "up front", honest, and as accurate 
as current knowledge allows. Nothing 
can be hidden or swept under the car-
o? pet, as this will only create long-term 
? problems that may become unsolvable. 
£ The introduction of transgenic bacu-
JJ lov i ruses as insect cont ro l agents hâve 
^ not met s igni f icant obstacles in the early 
£ stages of research and ini t ial f ie ld re-
o leases in smal l p lo ts , at least in the U.S. 
H However , w e can ant ic ipate that once a 
LU full commercial registration is sought, 
O issues will corne forth from the public 
£ sector which could require additional 
£ safety and environmental testing. Even 
^ after the approval of commercial sales, 
Û- there could be some résistance to the 
use of thèse products, based on igno-
rance, fear, or ethical reasons. This has 
clearly been the attitude of many Euro-
pean countries relative to transgenic 
crops. Although, recombinant baculov-
iruses hâve the advantage in not being 
incorporated into the crop. Your chal-
lenge will be to carry out this introduc-
tion and, meeting the informational 
needs to answer the societal issues of 
concern for each respective géographie 
unit (country, state, etc.). It can be 
expected that the concerns will be quite 
varied from country to country. This 
will be a major challenge for the OEDC 
to meet and solve in the years to corne. 
THE FUTURE 
Genetically engineered baculoviruses, 
with insect-specific toxin gènes insert-
ed, will become a commercial reality 
within the next 2 - 3 years. Thèse prod-
ucts will be limited to controlling only 
those hosts which are permissive to 
the infection of the wild-type baculov-
irus parents. This will remain a limiting 
factor for the widespread use of thèse 
baculoviruses. This limitation dictâtes 
the need to discover new baculoviral 
variants that hâve dif férent host-
ranges (e.g., congruent with the crop 
pest spectrum). This will be accom-
plished through the careful observation 
and search in the field for baculovirus-
es infecting new target hosts. Thèse 
baculovirus libraries will form the basis 
of genetic material from which to even-
tually draw and enable the génération 
of "designer baculoviruses" (second 
and third génération products) that will 
control insects in spécifie cropping scé-
narios. In the near future, researchers 
will discover the genetic basis for host-
range control of baculoviruses and will 
be able to mix-and-match the proper 
gènes to meet the pest control require-
ments of many crop scénarios. It is 
envisioned that thèse designer bacu-
loviruses could (at least initially) require 
some higher level of regulatory over-
sight. Finally, other viruses such as 
entomopox and granulosis viruses will 
émerge into the realm of transgenic 
baculovirus products. 
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SUMMARY 
In summary , we envis ion the rôle for 
OEDC members to help in educat ing 
the publ ic and overcoming the societal 
issues connected w i th the commerc ia l -
ization and ut i l izat ion of t ransgenic v i -
ruses for insect cont ro l . This act iv i ty is 
go ing to be essential to enable the 
widespread use of thèse recombinant 
products. This act iv i ty could require 
research to answer new publ ic issues, 
as wel l as to add fur ther suppor t to the 
database answer ing older quest ions. 
A lso, it w i l l be impor tant for OEDC re-
search to concentrate on ident i fy ing 
new genetic material that w i l l be usable 
in the deve lopment of other f i rst génér-
ation baculoviruses (i.e., host-range l im-
ited to the wi ld- type parent) and in the 
future, for construct ing second and th i rd 
générat ion designer baculoviruses. 
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QUESTIONS 
I. What cropping scénarios in OECD 
countr ies w o u l d benefi t f r om a re-
comb inan t baculovi ra l insecticide? 
Why? 
II. H o w w i l l OECD countr ies address the 
regulatory issues for release of re-
combinant baculoviruses? 
III. Wi l l there be dif férent issues (regu-
latory, ethical, etc.) to address in a 
release for test ing vs. a release for 
commerce? 
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